指南与共识流行病学与生物统计

原发性开角型青光眼的筛查:美国预防服务工作组推荐声明

Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement.
指南 / 共识 · JAMA · 2022-01-01

美国预防服务工作组(USPSTF)更新2013年推荐,委托系统综述评估成人青光眼筛查的获益与危害。工作组结论为当前证据不足以评估在成人中筛查原发性开角型青光眼的获益与危害平衡,推荐强度为I声明。

要点

  • USPSTF结论:当前证据不足以评估成人原发性开角型青光眼筛查的获益与危害平衡(I声明)。
  • 筛查人群为40岁及以上、在初级保健就诊且无开角型青光眼体征或症状的成人。
  • 工作组指出成人青光眼筛查的获益与危害不确定,需要更多研究。

核心结论

  • USPSTF结论为当前证据不足以评估成人原发性开角型青光眼筛查的获益与危害平衡,推荐强度为I声明。
  • 工作组指出成人青光眼筛查的获益与危害不确定,需要更多研究。

研究设计与样本

  • USPSTF为更新2013年推荐,委托系统综述评估成人青光眼筛查的获益与危害。
  • 目标人群为40岁及以上、在初级保健就诊且无开角型青光眼体征或症状的成人。

主要发现

  • USPSTF结论为证据不足以评估成人青光眼筛查的获益与危害平衡,获益与危害不确定,需要更多研究。

关键数值与推荐

  • 推荐强度为I声明:当前证据不足以评估成人原发性开角型青光眼筛查的获益与危害平衡。

临床怎么用

  • 原文未据此给出推荐,仅指出当前证据不足以评估成人原发性开角型青光眼筛查的获益与危害平衡。

局限性

  • USPSTF指出当前证据不足以评估成人青光眼筛查的获益与危害平衡,获益与危害不确定,需要更多研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons. OBJECTIVE: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults. POPULATION: Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma. EVIDENCE ASSESSMENT: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Mangione CM, Barry MJ, Nicholson WK, et al. Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement. JAMA. 2022. PMID: 35608574. doi:10.1001/jama.2022.7013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。